MetLife (NYSE: MET) investor files to sell 137 common shares under Rule 144
Rhea-AI Filing Summary
A holder of MetLife (MET) common stock filed a notice to sell 137 shares of common stock under Rule 144. The shares are to be sold through Bernstein Institutional Services LLC on or about 12/19/2025, with an indicated aggregate market value of 11,194.27. The filing notes that 658,891,656 shares of the issuer’s common stock were outstanding, providing context for the size of this planned sale.
The notice also lists multiple sales of the same issuer’s common stock over the prior three months by various MetLife-related accounts, each with its own share amount and gross proceeds. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does MetLife (MET)'s latest Form 144 filing disclose?
The filing discloses that a holder of MetLife common stock intends to sell 137 shares under Rule 144 through Bernstein Institutional Services LLC, with an aggregate market value of 11,194.27 and an approximate sale date of 12/19/2025.
What prior MetLife (MET) stock sales are reported in the past 3 months section?
The notice lists several sales of MetLife common stock over the past three months by entities such as Separate Account II, MetLife 401k Plan Trust-Large Cap Equity Index, Separate Account SPI, Separate Account 149, and MetLife 401k Plan Russell 1000 Value, each with specified dates, share amounts, and gross proceeds.
What representation does the seller make in MetLife (MET)'s Form 144?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and this also applies if a Rule 10b5-1 trading plan or instructions are in place.